- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2014 (2014), Article ID 134236, 8 pages
Dynamic of the Cellular Immune Response at the Dermal Site of Leishmania (L.) amazonensis and Leishmania (V.) braziliensis Infection in Sapajus apella Primate
1Infectious Diseases Laboratory (LIM-50), Pathology Department, Medical School of São Paulo University, Avenida Dr. Arnaldo, 455-1° Andar, Sala 1209, 01246-903 São Paulo, SP, Brazil
2Leishmaniasis Laboratory, Evandro Chagas Institute, Ministry of Health, Rodovia BR 316 s/n, 67030-000 Ananindeua, PA, Brazil
3Tropical Medicine Nucleus, Pará Federal University, Avenida Generalíssimo Deodoro 92, 66055-240 Belém, PA, Brazil
Received 10 February 2014; Revised 21 June 2014; Accepted 13 August 2014; Published 28 August 2014
Academic Editor: Amogh A. Sahasrabuddhe
Copyright © 2014 Márcia Dalastra Laurenti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The purpose of this study was to characterize the immunopathological response in the skin of S. apella infected with Leishmania (L.) amazonensis and L. (V.) braziliensis parasites, the main causative agents of localized cutaneous leishmaniasis in South America. In infected animals, amastigote forms of L. (L.) amazonensis could be detected till 120 days postinfection (PI), while, in L. (V.) braziliensis infection, parasites could be detected until 180 days PI in the skin sections. CD20+ cells were detected throughout the experimental time in both groups as well as in CD3+ cells, which appeared to be activated because high densities of inducible nitric oxide synthase (iNOS+) cells were detected at 60 and 90 days PI in both studied groups. After 60 and 120 days PI, decrease in iNOS+ cells was observed in L. (L.) amazonensis and L. (V.) braziliensis, respectively, which was associated with parasite clearance. Increase in lysozyme+ cells was observed during the experimental infections, which also can be associated with parasite killing.
Leishmaniasis is an infectious disease caused by different species of protozoa parasites, which is transmitted by sand fly bites. These protozoa are able to cause cutaneous and visceral form of the disease. Several reports have examined the pathogenesis of leishmaniasis in murine models aiming to characterize the mechanisms by which Leishmania parasites induce disease [1–5]. However, other reports state that some aspects of leishmaniasis immunopathogenesis cannot be completely represented using murine models since they are not the natural hosts for the parasites. Thus, a more reliable experimental model that mimics human infection is required. Nonhuman primates may represent an interesting tool for analyzing the aspects of human leishmaniasis immunopathology since they share 85–92% of their DNA with humans, indicating their close phylogenetic relationship with humans .
The Sapajus apella primate, previously known as Cebus apella, has been successfully used in experimental studies to analyze the dynamics of clinical and histological lesions during L. (L.) amazonensis, L. (V.) braziliensis, and L. (V.) lainsoni infections [7–9]. In these reports, all species of parasites were able to infect the primates. In addition, animals infected with L. (L.) amazonensis presented an apparent lesion 20 days postinfection (PI) with a nodular aspect recorded at 60 days PI; however, following L. (V.) braziliensis infection, lesions were observed approximately 15 days PI, with spontaneous ulceration verified after 3 months. Histologically, animals infected with L. (L.) amazonensis and L. (V.) braziliensis parasites showed a nonspecific inflammatory infiltrate during the initial phase of infection, characterized by macrophagic nodules, necrosis of inflammatory areas, and the presence of epithelioid granuloma. Absorption of necrotic areas and nonspecific residual inflammatory infiltration with cicatrisation was observed in both groups with disease evolution . Despite the similarities in lesion evolution and in self-healing processes, L. (L.) amazonensis-infected primates presented higher antibody levels than L. (V.) braziliensis-infected primates, suggesting different levels of immune response in both groups that determine the magnitude of disease .
Human cutaneous leishmaniasis caused by both of these parasite species showed similar immunopathological features at the dermal site of infection [11–13], supporting the idea that the S. apella primate can be used as an experimental model to mimic human disease [7–9]. Studies examining the immunopathogenesis of the L. (V.) braziliensis and L. (L.) amazonensis infection in humans have not been conclusive, and reports regarding the evolution of infection caused by these parasites species are limited. Thus, shared characteristics among nonhuman primates and humans can aid in the establishment of a very confident experimental model to study American cutaneous leishmaniasis. Since there is little information about the dynamics of cellular immune response in Leishmania-infected S. apella, the purpose of this study was to analyze the evolution of the immune response developed at the dermal site of L. (V.) braziliensis and L. (L.) amazonensis infection in the neotropical primate S. apella.
2. Material and Methods
In this study, we used 10 outbred young specimens of S. apella primate, aged 1 to 2 years, weighing between 1,280 and 1,870 g, from both genders, from the National Center of Primates, Ananindeua, PA, Brazil, where they were born from breeding captivity. Before starting the experiments, an indirect fluorescence antibody test (IFAT) and leishmanin skin test (LST) were carried out to exclude the possibility of prior Leishmania infection in the animals. The protocol was approved by the Institutional Animals Care and Use of the Evandro Chagas Institute (Ministry of Health, Brazil) and the Animal Care and Use Committee of São Paulo Medical School (0493/07).
L. (L.) amazonensis (IFLA/BR/67/PH8) isolated in Belém, PA, and L. (V.) braziliensis (MHOM/BR/88/M11.636) in Monte Dourado, PA, Brazil, were classified by monoclonal antibodies and isoenzymes at the Evandro Chagas Institute, Belém, PA, Brazil.
2.3. Experimental Infection
The animals were divided randomly in two experimental groups and then were intradermally infected with stationary phase promastigotes of L. (L.) amazonensis and L. (V.) braziliensis at six sites of the dorsal surface of the primate tail. Biopsies were collected at 30, 60, 90, 120, 150, and 180 days PI from one of the six sites of infection. Before being biopsied, animals were anesthetized with intramuscular injection of ketamine (20–25 mg/kg) and biopsies were performed using a 4-mm punch. Skin biopsies were fixed in 10% buffered formalin (pH 7.2) and processed by standard histological techniques and immunohistochemistry.
Briefly, slides with histological sections were deparaffinized and hydrated. Antigenic recovery was developed in citric acid solution (10 mM, pH 6.0) for 3 minutes in a pressure cooker. Next, the slides were washed six times with 3% hydrogen peroxide (H2O2) to block endogenous peroxidase and to avoid nonspecific ionic binding; the sections were also incubated in a solution of powdered skim milk 10%, diluted in phosphate buffered saline (PBS), pH 7.4 at room temperature for 30 minutes.
The immunolabeling reaction was performed with polyclonal antibodies: mouse anti-Leishmania at 1 : 1000 (produced in Laboratory of Pathology of Infectious Diseases) and rabbit anti-human lysozyme at 1 : 800 (A0099, Dako, Carpinteria, CA, USA), and monoclonal antibodies: mouse anti-human CD3 at 1 : 200 (M7254, Dako), rabbit anti-inducible nitric oxide synthase (iNOS) at 1 : 500 (SC-651, Santa Cruz Biotechnology, Santa Cruz, CA, USA), and mouse anti-human CD20 at 1 : 800 (M0755, Dako) diluted in PBS 1% BSA. For development of the reaction, the LSAB kit (Dako) and diaminobenzidine (Sigma, St. Louis, MO, USA) in PBS containing 3% hydrogen peroxide were used. Histological sections were counterstained in Harris’s hematoxylin, dehydrated, and mounted in resin with cover slides .
At least 10 sequential images of each histological section were acquired using a light microscope equipped with a color video camera connected to computer (Zeiss, Jena, Germany). Immunolabeled cells were quantified by counting in the software AxioVision 4.1 (Zeiss), and cell densities (cells/mm2) were calculated. Five biopsies from S. apella normal skin were used as negative control.
2.5. Statistical Analysis
The results are presented as vertical bars showing the low and high densities of each marker and expressed as the median ± standard error. The parametric test one-way analysis of variance with the Tukey post-test for multiple comparisons was employed to analyze the data. GraphPad Prism version 5 for Windows was used to analyze the results. Differences were considered statistically significant at a 5% significance level ().
3.1. Skin Parasitism
Primates infected with L. (L.) amazonensis showed parasites from 30 to 120 days PI with clearance since 150 days PI, when amastigote forms of the parasite could not be detected in the skin histological sections (Figure 1(a)). L. (V.) braziliensis-infected primates showed skin parasitism during all the period of the study with a peak between 60 and 90 days PI followed by a decrease since 120 days PI () (Figure 1(b)). Figures 2(a) and 2(b) illustrate amastigote forms in the skin tissue sections of S. apella primates infected with L. (L.) amazonensis and L. (V.) braziliensis at 60 days PI, respectively.
3.2. Cellular Immune Response at the Site of Parasite Inoculation
CD20+ cells could be detected since 30 days PI in L. (V.) braziliensis-infected primates and in L. (L.) amazonensis since 60 days PI. The density of CD20+ cells was similar during the evolution of both infections (Figures 1(c) and 1(d)) with a tendency to decrease with the evolution of the infection. Figures 2(c) and 2(d) illustrate CD20+ cells in the skin tissue sections of S. apella primates infected with L. (L.) amazonensis and L. (V.) braziliensis at 60 days PI, respectively.
CD3+ cells were observed in the skin of L. (V.) braziliensis and L. (L.) amazonensis infected primates since 30 days till 180 days PI with no difference during the evolution of the infection (Figures 1(e) and 1(f)). Figures 2(e) and 2(f) illustrate CD3+ cells in the skin tissue sections of S. apella primates infected with L. (L.) amazonensis and L. (V.) braziliensis at 60 days PI, respectively.
L. (L.) amazonensis-infected primates showed the presence of iNOS+ cells since 30 days PI. The density of cells was higher at 60 days PI followed by a significant decrease since 90 days PI () (Figure 1(g)). In the skin biopsies of Leishmania (V.) braziliensis-infected primates, iNOS+ cells were also detected since 30 days PI, which gradually increase peaking at 90 days PI, followed by a decrease at 120, 150, and 180 days PI () (Figure 1(h)). Interestingly, the iNOS response occurred earlier in L. (L.) amazonensis infection (60 days PI) than in L. (V.) braziliensis infection (90 days PI), and it was higher in L. (L.) amazonensis infection at 60 days PI (). Figures 2(g) and 2(h) illustrate iNOS+ cells in the skin tissue sections of S. apella primates infected with L. (L.) amazonensis and L. (V.) braziliensis at 60 days PI, respectively.
Lysozyme+ cells were observed since 30 days PI in both experimental groups. A significant increase in L. (L.) amazonensis-infected primates was observed at 60 days PI compared to at 30 days PI (Figure 1(i)), followed by a significant decrease since 90 days PI (). In contrast, L. (V.) braziliensis-infected primates showed a similar density of lysozyme+ cells till 150 days PI and a significant decrease was verified at 180 days PI compared to at 60 days PI () (Figure 1(j)). Notably, in L. (L.) amazonensis infection, a peaking of lysozyme+ cells was observed at 60 days PI and a significant number of stained cells were also observed at 90 days PI compared to L. (V.) braziliensis infection; however, L. (V.) braziliensis infection showed a persistence of lysozyme+ cells during the evolution of infection, with a higher density at 120 days PI compared to L. (L.) amazonensis infection (). Figures 2(i) and 2(j) illustrate lysozyme+ cells in the skin tissue sections of S. apella primates infected with L. (L.) amazonensis and L. (V.) braziliensis at 60 days PI, respectively.
Previous studies showed that S. apella primates infected with the L. (L.) amazonensis and L. (V.) braziliensis parasites develop clinical and histopathological skin lesions which spontaneously self-heal and resemble human localized cutaneous lesions [8, 9, 11]. Therefore, S. apella primates represent an experimental model of the host resistance since they are able to cure the infection with the parasite elimination.
In this study, the primates infected with L. (L.) amazonensis showed parasites from 30 to 120 days PI, and since 150 days PI no parasites were observed in the tissue. However, L. (V.) braziliensis-infected primates showed skin parasitism during all the period of the study, with a peak between 60 and 90 days PI, followed by a decrease since 120 to 180 days PI. These results show that L. (L.) amazonensis and L. (V.) braziliensis parasites induce, in the S. apella primate, a distinct profile of infection, which is closely related to the ability of both parasite species to induce disease and trigger immunity .
From the immunopathological perspective, the localized cutaneous leishmaniasis consists of one or more ulcerated skin lesions with the involvement of T and B cells at the lesion site . Together with antigen-presenting cells, B cells participate in the pathogenesis of the lesion by capturing parasite antigens  and presenting them to T cells, as well as by antibodies producing, which are not protective to the host . In this study, no significant differences were detected in the densities of CD20+ cells during infections caused either by L. (L.) amazonensis or by L. (V.) braziliensis. In contrast, the priming and activation of T cells by antigen-presenting cells are required for promoting self-healing or progression of lesions [19–21]. In both of the experimental groups, T cells were present in similar numbers during the evolution of the infection. Since parasitism was drastically decreased in L. (V.) braziliensis infection at 120 days PI and it was also eliminated in L. (L.) amazonensis infection at 150 days PI, efficient priming and activation of T-cell may have occurred during the course of infection in both infections.
The efficient activation of T cells is important for triggering the production of IFN-, which activates macrophage cells towards leishmanicidal mechanisms. IFN--activated macrophages express iNOS enzyme, which catalyzes nitric oxide production from L-arginine . This immunological pathway is essential for killing intracellular pathogens, such as Leishmania sp.; therefore, high expression of the iNOS enzyme is a key requirement for eliminating intracellular amastigotes in the vertebrate hosts . In L. (L.) amazonensis-infected primates, high densities of iNOS+ cells were detected mainly at 60 days PI, which probably had an important role in the control and clearance of parasites in the skin of S. apella primate, which occur at 150 days PI. In L. (V.) braziliensis infection, iNOS+ cells reached higher densities between 60 and 90 days PI, however, in lower densities compared to L. (L.) amazonensis infection. Interestingly, in L. (V.) braziliensis infection, few parasites persisted in the skin until the end of the experimental time, which could be a direct result of the lower number of iNOS+ cells presented in this group. In addition, other mechanisms may collaborate to the parasite control and clearance, such as those based on lysozyme production.
Lysozyme is an antimicrobial peptide that is part of the innate immune response and can be produced by neutrophils, monocytes, and macrophages  and it appears to participate in microbial mechanisms for parasite destruction . In L. (L.) amazonensis-infected primates, increase in the density of lysozyme+ cells was directly correlated with the increase in the number of iNOS+ cells at 60 days PI, suggesting that parasite elimination could have occurred by both of these activation mechanisms. In contrast, in L. (V.) braziliensis-infected primates, the density of lysozyme+ cells was similar throughout the infection, and at 90 and 120 days PI it was lower than that observed in primates infected with L. (L.) amazonensis, indicating that parasite destruction occurs predominantly through mechanisms involving nitric oxide. Lysozyme may play a role in parasite destruction; however, it participates to a lower extent than nitric oxide in both groups since the densities of lysozyme+ cells were lower than those of iNOS+ cells in the inflammatory infiltrate of S. apella skin.
The present results indicate that S. apella primates are interesting models to evaluate immunological parameters related to self-healing in localized cutaneous leishmaniasis, caused by both L. (L.) amazonensis and L. (V.) braziliensis. These results indicate that the resistance against the infection can be triggered by components of both innate and acquired immunity. Differences in parasite species and its immunomodulatory properties on the vertebrate host cells impact the outcome of infection, as observed in the evolution of the infection caused by L. (L.) amazonensis and L. (V.) braziliensis in S. apella primate.
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
This project was supported by grant 2006/56319-1, São Paulo Research Foundation (FAPESP) and LIM50 HC-FMUSP. Marcia Dalastra Laurenti is research fellow from CNPq, Brazil.
- M. Colmenares, S. Kar, K. Goldsmith-Pestana, and D. McMahon-Pratt, “Mechanisms of pathogenesis: differences amongst Leishmania species,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 96, no. 1, pp. S3–S7, 2002.
- A. Strazzulla, S. Cocuzza, M. R. Pinzone et al., “Mucosal leishmaniasis: an underestimated presentation of a neglected disease,” BioMed Research International, vol. 2013, Article ID 805108, 7 pages, 2013.
- D. McMahon-Pratt and J. Alexander, “Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?” Immunological Reviews, vol. 201, pp. 206–224, 2004.
- L. F. D. Passero, J. V. Sacomori, T. Y. Tomokane, C. E. P. Corbett, F. T. da Silveira, and M. D. Laurenti, “Ex vivo and in vivo biological behavior of Leishmania (Viannia) shawi,” Parasitology Research, vol. 105, no. 6, pp. 1741–1747, 2009.
- A. Gomes-Silva, J. G. Valverde, R. P. Ribeiro-Romão, R. M. Plácido-Pereira, and A. M. Da-Cruz, “Golden hamster (Mesocricetus auratus) as an experimental model for Leishmania (Viannia) braziliensis infection,” Parasitology, vol. 140, no. 6, pp. 771–779, 2013.
- F. A. King, C. J. Yarbrough, D. C. Anderson, T. P. Gordon, and K. G. Gould, “Primates,” Science, vol. 240, no. 4858, pp. 1475–1482, 1988.
- F. T. Silveira, R. Lainson, J. J. Shaw et al., “Experimental cutaneous leishmaniasis: I—on the susceptibility of the primata Cebus apella (Cebidae) to the infection by Leishmania (Viannia) lainsoni Silveira, Shaw, Braga and Ishikawa,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 22, no. 3, pp. 125–130, 1989.
- F. T. Silveira, R. Lainson, J. J. Shaw et al., “Experimental cutaneous leishmaniasis: II. Evolutive aspects of infection in the primate Cebus apella (Cebidae) with Leishmania (V.) braziliensis and L. (L.) amazonesis,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 23, no. 1, pp. 5–12, 1990.
- F. T. Silveira, M. A. Moraes, R. Lainson, and J. J. Shaw, “Experimental cutaneous leishmaniasis. III. Histopathological aspects of the developmental behavior of the cutaneous lesion induced in Cebus apella (Primates: Cebidae) by Leishmania (Viannia) lainsoni, L. (V.) braziliensis and L. (Leishmania) amazonensis,” Revista do Instituto de Medicina Tropical de Sao Paulo, vol. 32, no. 6, pp. 387–394, 1990.
- L. M. Garcez, F. T. Silveira, A. El Harith, R. Lainson, and J. Jon Shaw, “Experimental cutaneous leishmaniasis IV. The humoral response of Cebus apella (Primates: Cebidae) to infections of Leishmania (Leishmania) amazonensis, L. (Viannia) lainsoni and L. (V.) braziliensis using the direct agglutination test,” Acta Tropica, vol. 68, no. 1, pp. 65–76, 1997.
- F. T. Silveira, R. Lainson, and C. E. P. Corbett, “Clinical and immunopathological spectrum of american cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review,” Memorias do Instituto Oswaldo Cruz, vol. 99, no. 3, pp. 239–251, 2004.
- A. G. Viana, W. Mayrink, C. A. de Carvalho Fraga et al., “Histopathological and immunohistochemical aspects of American cutaneous leishmaniasis before and after different treatments,” Anais Brasileiros de Dermatologia, vol. 88, no. 1, pp. 32–40, 2013.
- Y. Gutierrez, G. H. Salinas, G. Palma, L. B. Valderrama, C. V. Santrich, and N. G. Saravia, “Correlation between histopathology, immune response, clinical presentation, and evolution in Leishmania braziliensis infection,” The American Journal of Tropical Medicine and Hygiene, vol. 45, no. 3, pp. 281–289, 1991.
- A. K. Carvalho, F. T. Silveira, L. F. D. Passero, C. M. C. Gomes, C. E. P. Corbett, and M. D. Laurenti, “Leishmania (V.) braziliensis and L. (L.) amazonensis promote differential expression of dendritic cells and cellular immune response in murine model,” Parasite Immunology, vol. 34, no. 8-9, pp. 395–403, 2012.
- F. T. Silveira, R. Lainson, C. M. de Castro Gomes, M. D. Laurenti, and C. E. P. Corbett, “Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis,” Parasite Immunology, vol. 31, no. 8, pp. 423–431, 2009.
- C. Souza-Lemos, S. N. de-Campos, A. Teva, R. Porrozzi, and G. Grimaldi Jr., “In situ characterization of the granulomatous immune response with time in nonhealing lesional skin of Leishmania braziliensis-infected rhesus macaques (Macaca mulatta),” Veterinary Immunology and Immunopathology, vol. 142, no. 3-4, pp. 147–155, 2011.
- D. Rodríguez-Pinto, “B cells as antigen presenting cells,” Cellular Immunology, vol. 238, no. 2, pp. 67–75, 2005.
- N. Wanasen, L. Xin, and L. Soong, “Pathogenic role of B cells and antibodies in murine Leishmania amazonensis infection,” International Journal for Parasitology, vol. 38, no. 3-4, pp. 417–429, 2008.
- J. W. J. Moore, L. Beattie, J. E. Dalton et al., “B cell: T cell interactions occur within hepatic granulomas during experimental visceral leishmaniasis,” PLoS ONE, vol. 7, no. 3, Article ID e34143, 2012.
- C. Pirmez, M. Yamamura, K. Uyemura, M. Paes-Oliveira, F. Conceicao-Silva, and R. L. Modlin, “Cytokine patterns in the pathogenesis of human Leishmaniasis,” The Journal of Clinical Investigation, vol. 91, no. 4, pp. 1390–1395, 1993.
- E. M. Carvalho, D. C. Filho, O. Bacellar, R. P. Almeida, H. Lessa, and H. Rocha, “Characterization of the immune response in subjects with self-healing cutaneous Leishmaniasis,” The American Journal of Tropical Medicine and Hygiene, vol. 53, no. 3, pp. 273–277, 1995.
- T. Van Assche, M. Deschacht, R. A. I. Da Luz, L. Maes, and P. Cos, “Leishmania-macrophage interactions: insights into the redox biology,” Free Radical Biology and Medicine, vol. 51, no. 2, pp. 337–351, 2011.
- M. Shweash, H. A. McGachy, J. Schroeder et al., “Leishmania mexicana promastigotes inhibit macrophage IL-12 production via TLR-4 dependent COX-2, iNOS and arginase-1 expression,” Molecular Immunology, vol. 48, no. 15-16, pp. 1800–1808, 2011.
- R. Swaminathan, V. K. Ravi, S. Kumar, M. V. S. Kumar, and N. Chandra, “Lysozyme: a model protein for amyloid research,” Advances in Protein Chemistry and Structural Biology, vol. 84, pp. 63–111, 2011.
- J. Wiesner and A. Vilcinskas, “Antimicrobial peptides: the ancient arm of the human immune system,” Virulence, vol. 1, no. 5, pp. 440–464, 2010.